Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 196

1.

Cyclin-dependent kinase 5 activators p35 and p39 facilitate formation of functional synapses.

Johansson JU, Lilja L, Chen XL, Higashida H, Meister B, Noda M, Zhong ZG, Yokoyama S, Berggren PO, Bark C.

Brain Res Mol Brain Res. 2005 Aug 18;138(2):215-27.

PMID:
15908038
2.

p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment.

Ko J, Humbert S, Bronson RT, Takahashi S, Kulkarni AB, Li E, Tsai LH.

J Neurosci. 2001 Sep 1;21(17):6758-71.

4.

p39 Is Responsible for Increasing Cdk5 Activity during Postnatal Neuron Differentiation and Governs Neuronal Network Formation and Epileptic Responses.

Li W, Allen ME, Rui Y, Ku L, Liu G, Bankston AN, Zheng JQ, Feng Y.

J Neurosci. 2016 Nov 2;36(44):11283-11294.

5.

Cyclin-dependent kinase 5 associated with p39 promotes Munc18-1 phosphorylation and Ca(2+)-dependent exocytosis.

Lilja L, Johansson JU, Gromada J, Mandic SA, Fried G, Berggren PO, Bark C.

J Biol Chem. 2004 Jul 9;279(28):29534-41. Epub 2004 Apr 26.

6.

p39 activates cdk5 in neurons, and is associated with the actin cytoskeleton.

Humbert S, Dhavan R, Tsai L.

J Cell Sci. 2000 Mar;113 ( Pt 6):975-83.

7.

Synaptic localization of p39, a neuronal activator of cdk5.

Humbert S, Lanier LM, Tsai LH.

Neuroreport. 2000 Jul 14;11(10):2213-6.

PMID:
10923673
9.

Preferential targeting of p39-activated Cdk5 to Rac1-induced lamellipodia.

Ito Y, Asada A, Kobayashi H, Takano T, Sharma G, Saito T, Ohta Y, Amano M, Kaibuchi K, Hisanaga S.

Mol Cell Neurosci. 2014 Jul;61:34-45. doi: 10.1016/j.mcn.2014.05.006. Epub 2014 May 27.

PMID:
24877974
10.

p39, the primary activator for cyclin-dependent kinase 5 (Cdk5) in oligodendroglia, is essential for oligodendroglia differentiation and myelin repair.

Bankston AN, Li W, Zhang H, Ku L, Liu G, Papa F, Zhao L, Bibb JA, Cambi F, Tiwari-Woodruff SK, Feng Y.

J Biol Chem. 2013 Jun 21;288(25):18047-57. doi: 10.1074/jbc.M113.453688. Epub 2013 May 3.

11.

The regulation of cyclin-dependent kinase 5 activity through the metabolism of p35 or p39 Cdk5 activator.

Hisanaga S, Saito T.

Neurosignals. 2003 Sep-Oct;12(4-5):221-9. Review.

PMID:
14673209
13.

Pctaire1 interacts with p35 and is a novel substrate for Cdk5/p35.

Cheng K, Li Z, Fu WY, Wang JH, Fu AK, Ip NY.

J Biol Chem. 2002 Aug 30;277(35):31988-93. Epub 2002 Jun 25.

14.

Phosphorylation of p35 and p39 by Cdk5 determines the subcellular location of the holokinase in a phosphorylation-site-specific manner.

Asada A, Saito T, Hisanaga S.

J Cell Sci. 2012 Jul 15;125(Pt 14):3421-9. doi: 10.1242/jcs.100503. Epub 2012 Mar 30.

15.

Cdk5--p39 is a labile complex with the similar substrate specificity to Cdk5--p35.

Yamada M, Saito T, Sato Y, Kawai Y, Sekigawa A, Hamazumi Y, Asada A, Wada M, Doi H, Hisanaga SI.

J Neurochem. 2007 Sep;102(5):1477-1487. doi: 10.1111/j.1471-4159.2007.04505.x. Epub 2007 Mar 29.

16.

Structural basis for the different stability and activity between the Cdk5 complexes with p35 and p39 activators.

Saito T, Yano M, Kawai Y, Asada A, Wada M, Doi H, Hisanaga S.

J Biol Chem. 2013 Nov 8;288(45):32433-9. doi: 10.1074/jbc.M113.512293. Epub 2013 Sep 30.

17.
18.

Activation of latent cyclin-dependent kinase 5 (Cdk5)-p35 complexes by membrane dissociation.

Zhu YS, Saito T, Asada A, Maekawa S, Hisanaga S.

J Neurochem. 2005 Sep;94(6):1535-45. Epub 2005 Jun 30.

19.

Phosphorylation of cyclin-dependent kinase 5 (Cdk5) at Tyr-15 is inhibited by Cdk5 activators and does not contribute to the activation of Cdk5.

Kobayashi H, Saito T, Sato K, Furusawa K, Hosokawa T, Tsutsumi K, Asada A, Kamada S, Ohshima T, Hisanaga S.

J Biol Chem. 2014 Jul 11;289(28):19627-36. doi: 10.1074/jbc.M113.501148. Epub 2014 May 28.

20.

Supplemental Content

Support Center